Zinc in rheumatic heart valves.
This study included 48 patients with chronic rheumatic heart disease, 60 control subjects for plasma zinc comparison and 20 control specimens of heart valves from postmortem cases of accident deaths. Plasma and cardiac tissue levels of zinc in patients with rheumatic heart disease were significantly lowered compared to controls. Since zinc is important in the synthesis of nucleic acids and proteins it may influence tissue growth, reparative process and structure and function of biomembrane. Low zinc levels may also influence cell mediated immunity and may increase susceptibility of patients to infection and increased rheumatic activity which needs further study.